Your browser doesn't support javascript.
loading
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials.
Rodríguez-Arbolí, Eduardo; Lee, Catherine J; Caballero-Velázquez, Teresa; Martínez, Carmen; García-Calderón, Clara; Jiménez-León, María Reyes; Bermúdez-Rodríguez, María Aránzazu; López-Corral, Lucía; Triguero, Ana; Onstad, Lynn; Horwitz, Mitchell E; Sarantopoulos, Stefanie; Lee, Stephanie J; Pérez-Simón, José Antonio.
Affiliation
  • Rodríguez-Arbolí E; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville Biomedicine Institute (IBiS/CSIC), University of Seville, Seville, Spain.
  • Lee CJ; Utah Blood and Marrow Transplant Program, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Caballero-Velázquez T; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville Biomedicine Institute (IBiS/CSIC), University of Seville, Seville, Spain.
  • Martínez C; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, IDIBAPS, Josep Carreras Research Institute, Hospital Clínic, Barcelona, Spain.
  • García-Calderón C; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville Biomedicine Institute (IBiS/CSIC), University of Seville, Seville, Spain.
  • Jiménez-León MR; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville Biomedicine Institute (IBiS/CSIC), University of Seville, Seville, Spain.
  • Bermúdez-Rodríguez MA; Department of Hematology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • López-Corral L; Department of Hematology, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain.
  • Triguero A; Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Hematology and Oncology, IDIBAPS, Josep Carreras Research Institute, Hospital Clínic, Barcelona, Spain.
  • Onstad L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Duke Cancer Institute, Durham, NC.
  • Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Duke Cancer Institute, Durham, NC.
  • Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Pérez-Simón JA; Department of Hematology, Hospital Universitario Virgen del Rocío, Seville Biomedicine Institute (IBiS/CSIC), University of Seville, Seville, Spain.
Clin Cancer Res ; 29(20): 4057-4067, 2023 Oct 13.
Article in En | MEDLINE | ID: mdl-37698881
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: España